家族性主动脉疾病史不影响复杂主动脉瘤开窗分支腔内修复术的预后
本研究基于2013至2022年前瞻性非随机研究数据,回顾499例接受开窗分支腔内主动脉修复术(FB-EVAR)的复杂主动脉瘤患者,其中66例(13%)有家族性主动脉瘤(FAA),434例(87%)为散发性。结果显示FAA组与SAA组在30天死亡率、主要不良事件及中期生存率、再干预率和瘤囊缩小方面均无显著差异。
要点
- FB-EVAR在FAA患者中技术成功率高、死亡率低,与散发性患者相当。
- FAA患者透视时间和辐射暴露显著高于SAA患者,但临床结局无差异。
- 家族史不应单独作为排除复杂腔内修复的依据,应更关注解剖适合性。
核心结论
- FB-EVAR治疗复杂主动脉瘤时,无论是否存在家族性主动脉疾病史,均能获得高技术成功率、低死亡率和低主要不良事件发生率。
- FAA与SAA患者在中期的患者生存率、二次干预率和瘤囊变化方面无差异。
研究设计与样本
- 回顾性分析2013至2022年前瞻性非随机研究连续入组患者的临床数据。
- 共纳入499例接受FB-EVAR的复杂主动脉瘤患者,FAA组66例(13%),SAA组434例(87%)。
- FAA定义为一级或二级亲属发生主动脉瘤或夹层。
主要发现
- FAA组与SAA组在人口学、临床特征、动脉瘤范围和既往主动脉夹层或修复史方面相似。
- FAA组透视时间82分钟 vs SAA组71分钟,辐射暴露1856 mGy vs 1213 mGy,差异均有统计学意义(p<0.05)。
- 技术成功率FAA组94% vs SAA组97%(p=0.51),30天死亡率1.5% vs 0.9%(p=1.00),主要不良事件23% vs 18%(p=0.44)。
- 中位随访28个月,3年总体患者生存率76±2.5%,免于二次干预率74±2.5%,瘤囊缩小累积发生率32±2.6%,FAA与SAA组间无差异。
临床怎么用
- 对于解剖适合的家族性主动脉瘤患者,可考虑FB-EVAR作为开放手术的替代方案。
- 临床决策应基于解剖 suitability 而非单纯家族史。
- FAA患者接受FB-EVAR时需注意透视时间和辐射暴露较高,但早期和中期结局与散发性患者相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Familial history of aortic disease has been associated with increased risk of aneurysm-related complications after standard endovascular aortic repair. The aim of this study was to evaluate outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) for complex aortic aneurysms in patients with or without familial aortic aneurysms (FAAs). MATERIALS AND METHODS: We reviewed the clinical data of consecutive patients enrolled in a prospective non-randomized study to investigate outcomes after FB-EVAR for treatment of complex aortic aneurysms between 2013 and 2022. Familial aortic aneurysm was defined as occurrence of an aortic aneurysm or dissections in a first- or second-degree relative and compared with patients with sporadic aortic aneurysms (SAAs). Endpoints included procedural metrics, 30-day mortality and major adverse events (MAEs), mid-term patient survival, freedom from reintervention and endoleak, and aneurysm sac shrinkage. RESULTS: There were 499 patients treated with FB-EVAR (70% males, mean age was 74±7.7 years) including 66 (13%) patients with FAAs and 434 (87%) with SAAs. Both groups had similar demographics, clinical characteristics, aneurysm extent, and prior history of aortic dissection or aortic repair. Patients with FAAs had longer fluoroscopy time (82 vs 71 minutes) and radiation exposure (1856 vs 1213 mGy; each p<0.05), with no difference in technical success (FAA, 94% vs SAA, 97%; p=0.51). There was no difference in 30-day mortality (1.5% vs 0.9%; p=1.00) and MAEs (23% vs 18%; p=0.44) among patients with FAA and SAA, respectively. Median follow-up was 28 months. At 3 years, patient survival, freedom from secondary interventions, and cumulative incidence of sac shrinkage were 76±2.5%, 74±2.5%, and 32±2.6% for all patients, respectively, with no difference between FAA and SAA groups. CONCLUSION: Fenestrated-branched endovascular aortic repair was performed with high technical success, low mortality, and low incidence of MAEs regardless of the presence of FAA. There was no difference in mid-term patient survival, secondary interventions, and sac changes among patients with or without family history of aortic disease.Clinical ImpactThis study demonstrates that fenestrated-branched endovascular aortic repair (FB-EVAR) can be performed with high technical success and comparable early and mid-term outcomes in patients with or without a familial history of aortic aneurysm, after exclusion of genetically triggered aortic diseases. These findings challenge the assumption that family history alone should preclude complex endovascular repair. Clinically, this supports broader use of FB-EVAR in carefully selected patients with familial aortic disease, emphasizing anatomical suitability rather than pedigree alone. The innovation lies in validating FB-EVAR as a safe alternative to open repair for this understudied population, informing patient selection, counseling, and surveillance strategies.
引用
- Baghbani A, Savadi S, Sulzer TAL, et al. Familial History of Aortic Disease Does Not Affect Outcomes of Fenestrated-Branched Endovascular Aortic Repair in Patients With Complex Aortic Aneurysms. J Endovasc Ther. 2026. PMID: 41664301. doi:10.1177/15266028261417156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。